Zhang, H., Yang, Y., Li, J., Wang, M., Saravanan, K. M., Wei, J., . . . Sciences, S. o. B. (2021). A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
Chicago Style CitationZhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.
MLA CitationZhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.
Warning: These citations may not always be 100% accurate.